Pathstone Holdings LLC Buys 1,228 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Pathstone Holdings LLC lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 48,928 shares of the medical equipment provider's stock after buying an additional 1,228 shares during the period. Pathstone Holdings LLC's holdings in Intuitive Surgical were worth $24,037,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of ISRG. Capital World Investors increased its position in Intuitive Surgical by 1.0% during the 1st quarter. Capital World Investors now owns 7,284,269 shares of the medical equipment provider's stock worth $2,907,079,000 after purchasing an additional 73,634 shares during the period. Baillie Gifford & Co. lifted its holdings in Intuitive Surgical by 0.6% in the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider's stock valued at $1,890,676,000 after acquiring an additional 24,183 shares during the period. American Century Companies Inc. boosted its position in shares of Intuitive Surgical by 3.0% during the 2nd quarter. American Century Companies Inc. now owns 2,398,193 shares of the medical equipment provider's stock worth $1,066,837,000 after purchasing an additional 70,556 shares in the last quarter. Clearbridge Investments LLC grew its stake in shares of Intuitive Surgical by 1.6% during the 2nd quarter. Clearbridge Investments LLC now owns 1,981,297 shares of the medical equipment provider's stock worth $881,380,000 after purchasing an additional 30,449 shares during the period. Finally, Assenagon Asset Management S.A. lifted its stake in shares of Intuitive Surgical by 15.4% in the second quarter. Assenagon Asset Management S.A. now owns 1,483,406 shares of the medical equipment provider's stock valued at $659,893,000 after purchasing an additional 197,841 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the sale, the senior vice president now directly owns 3,001 shares in the company, valued at $1,461,006.84. This represents a 93.06 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Jamie Samath sold 269 shares of the business's stock in a transaction on Monday, November 11th. The stock was sold at an average price of $539.89, for a total value of $145,230.41. Following the transaction, the insider now directly owns 8,757 shares of the company's stock, valued at $4,727,816.73. This trade represents a 2.98 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 91,178 shares of company stock valued at $45,897,071. 0.80% of the stock is owned by insiders.

Intuitive Surgical Trading Up 0.6 %

Shares of Intuitive Surgical stock traded up $3.00 during trading on Wednesday, reaching $541.82. The stock had a trading volume of 984,907 shares, compared to its average volume of 1,456,895. The company has a market capitalization of $192.98 billion, a price-to-earnings ratio of 86.63, a P/E/G ratio of 5.19 and a beta of 1.39. The stock has a fifty day moving average price of $501.42 and a two-hundred day moving average price of $460.69. Intuitive Surgical, Inc. has a 52 week low of $304.50 and a 52 week high of $544.38.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The firm had revenue of $2.04 billion for the quarter, compared to analysts' expectations of $2.01 billion. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on ISRG shares. Robert W. Baird upped their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an "outperform" rating in a research report on Thursday, October 17th. Mizuho lifted their price objective on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Truist Financial upped their target price on Intuitive Surgical from $520.00 to $570.00 and gave the company a "buy" rating in a report on Monday, October 14th. Oppenheimer reiterated a "market perform" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, JPMorgan Chase & Co. lifted their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the stock an "overweight" rating in a research report on Friday, October 11th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $524.61.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.